Gambaran keseluruhan

Kewangan

Perbincangan Teknikal Bermusim

EBIT untuk Regencell Bioscience Holdings Limited.

Data tahunan

2020

2021

2022

2023

2024

TTM

‪‪−8.00 M‬‬

‪‪−6.00 M‬‬

‪‪−4.00 M‬‬

‪‪−2.00 M‬‬

‪0.00‬

Tempoh

Nilai

Perubahan

% Perubahan

TTM

‪‪−4.74 M‬‬

‪0.00‬

‪0.00‬%

2024

‪‪−4.74 M‬‬

+‪‪1.54 M‬‬

+‪24.50‬%

2023

‪‪−6.27 M‬‬

+‪‪1.34 M‬‬

+‪17.64‬%

2022

‪‪−7.62 M‬‬

‪‪−6.24 M‬‬

‪−451.47‬%

2021

‪‪−1.38 M‬‬

‪‪−568.99 K‬‬

‪−70.04‬%

2020

‪‪−812.37 K‬‬

‪‪−421.38 K‬‬

‪−107.77‬%

Data separuh tahunan

H2 '22

H1 '23

H2 '23

H1 '24

H2 '24

‪‪−4.00 M‬‬

‪‪−3.00 M‬‬

‪‪−2.00 M‬‬

‪‪−1.00 M‬‬

‪0.00‬

Tempoh

Nilai

Perubahan

% Perubahan

H2 '24

‪‪−2.42 M‬‬

‪‪−113.01 K‬‬

‪−4.89‬%

H1 '24

‪‪−2.31 M‬‬

+‪‪532.29 K‬‬

+‪18.72‬%

H2 '23

‪‪−2.84 M‬‬

+‪‪585.37 K‬‬

+‪17.07‬%

H1 '23

‪‪−3.43 M‬‬

+‪‪529.34 K‬‬

+‪13.37‬%

H2 '22

‪‪−3.96 M‬‬

‪‪−299.95 K‬‬

‪−8.20‬%